Psychiatry - First Aid Flashcards

(195 cards)

1
Q

Psychology:

  • learning in which a natural response (salivation) is elicited by a conditioned, or learned, stimulus (bell) that previously was presented in conjunction with an unconditioned stimulus (food)
  • usually deals with involuntary responses
  • Pavlov’s classical experiments with dogs—ringing the bell provoked salivation
A

Classical Conditioning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Psychology:

  • learning in which a particular action is elicited because it produces a punishment or reward
  • usually deals with voluntary responses
A

Operant Conditioning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Operant Conditioning:

target behavior (response) is followed by desired reward (positive reinforcement) or removal of aversive stimulus (negative reinforcement)

A

Reinforcement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Operant Conditioning:

  • discontinuation of reinforcement (positive or negative) eventually eliminates behavior
  • can occur in operant or classical conditioning
A

Extinction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Operant Conditioning:

repeated application of aversive stimulus (positive punishment) or removal of desired reward (negative punishment) to extinguish unwanted behavior (Skinner’s operant conditioning quadrant)

A

Punishment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Psychology:

patient projects feelings about formative or other important persons onto physician (eg. psychiatrist is seen as parent)

A

Transference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Psychology:

doctor projects feelings about formative or other important persons onto patient (eg. patient reminds physician of younger sibling)

A

Countertransference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Psychology:

mental processes (unconscious or conscious) used to resolve conflict and prevent undesirable feelings (eg. anxiety, depression)

A

Ego Defenses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ego Defenses:

Immature

A
  • Acting Out
  • Denial
  • Displacement
  • Dissociation
  • Fixation
  • Idealization
  • Identification
  • Intellectualization
  • Isolation of Affect
  • Passive Aggression
  • Projection
  • Rationalization
  • Reaction Formation
  • Regression
  • Repression
  • Splitting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Immature Ego Defenses:

  • expressing unacceptable feelings and thoughts through actions
  • A young boy throws a temper tantrum when he does not get the toy he wants.
A

Acting Out

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Immature Ego Defenses:

  • avoiding the awareness of some painful reality
  • A patient with cancer plans a full-time work schedule despite being warned of significant fatigue during chemotherapy.
A

Denial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Immature Ego Defenses:

  • redirection of emotions or impulses to a neutral person or object (vs. projection)
  • A teacher is yelled at by the principal. Instead of confronting the principal directly, the teacher goes home and criticizes her husband’s dinner selection.
A

Displacement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Immature Ego Defenses:

  • temporary, drastic change in personality, memory, consciousness, or motor behavior to avoid emotional stress
  • patient has incomplete or no memory of traumatic event
  • A victim of sexual abuse suddenly appears numb and detached when she is exposed to her abuser.
A

Dissociation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Immature Ego Defenses:

  • partially remaining at a more childish level of development (vs. regression)
  • A surgeon throws a tantrum in the operating room because the last case ran very late.
A

Fixation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Immature Ego Defenses:

  • expressing extremely positive thoughts of self and others while ignoring negative thoughts
  • A patient boasts about his physician and his accomplishments while ignoring any flaws.
A

Idealization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Immature Ego Defenses:

  • largely unconscious assumption of the characteristics, qualities, or traits of another person or group
  • A resident starts putting his stethoscope in his pocket like his favorite attending, instead of wearing it around his neck like before.
A

Identification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Immature Ego Defenses:

  • using facts and logic to emotionally distance oneself from a stressful situation
  • In a therapy session, patient diagnosed with cancer focuses only on rates of survival.
A

Intellectualization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Immature Ego Defenses:

  • separating feelings from ideas and events
  • Describing murder in graphic detail with no emotional response.
A

Isolation of Affect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Immature Ego Defenses:

  • demonstrating hostile feelings in a nonconfrontational manner
  • showing indirect opposition
  • Disgruntled employee is repeatedly late to work, but won’t admit it is a way to get back at the manager.
A

Passive Aggression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Immature Ego Defenses:

  • atributing an unacceptable internal impulse to an external source (vs. displacement)
  • A man who wants to cheat on his wife accuses his wife of being unfaithful.
A

Projection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Immature Ego Defenses:

  • proclaiming logical reasons for actions actually performed for other reasons, usually to avoid self-blame
  • After getting fired, claiming that the job was not important anyway.
A

Rationalization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Immature Ego Defenses:

  • replacing a warded-off idea or feeling with an (unconsciously derived) emphasis on its opposite (vs. sublimation)
  • A patient with lustful thoughts enters a monastery.
A

Reaction Formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Immature Ego Defenses:

  • involuntarily turning back the maturational clock and going back to earlier modes of dealing with the world (vs. fixation)
  • Seen in children under stress such as illness, punishment, or birth of a new sibling (eg. bedwetting in a previously toilet-trained child).
A

Regression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Immature Ego Defenses:

  • involuntarily withholding an idea or feeling from conscious awareness (vs. suppression)
  • A 20-year-old does not remember going to counseling during his parents’ divorce 10 years earlier.
A

Repression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Immature Ego Defenses: * believing that people are either all good or all bad at different times due to intolerance of ambiguity * commonly seen in borderline personality disorder * A patient says that all the nurses are cold and insensitive but that the doctors are warm and friendly.
Splitting
26
Ego Defenses: Mature
**Mature** adults wear a **SASH**. * **S**ublimation * **A**ltruism * **S**uppression * **H**umor
27
Mature Ego Defenses: * replacing an unacceptable wish with a course of action that is similar to the wish but socially acceptable (vs. reaction formation) * Teenager’s aggressive urges toward his parents’ high expectations are channeled into excelling in sports.
Sublimation
28
Mature Ego Defenses: * alleviating negative feelings via unsolicited generosity, which provides gratification (vs. reaction formation) * Mafia boss makes large donation to charity.
Altruism
29
Mature Ego Defenses: * intentionally withholding an idea or feeling from conscious awareness (vs. repression) * temporary * Choosing to not worry about the big game until it is time to play.
Suppression
30
Mature Ego Defenses: * appreciating the amusing nature of an anxietyprovoking or adverse situation * Nervous medical student jokes about the boards.
Humor
31
Infant Deprivation Effects
* Long-term deprivation of affection results in: * failure to thrive * poor language/socialization skills * lack of basic trust * reactive attachment disorder (infant withdrawn/unresponsive to comfort) * disinhibited social engagement (infant indiscriminately attaches to strangers) * Deprivation for \> 6 months can lead to irreversible changes. * Severe deprivation can result in infant death.
32
Child Abuse: Physical Abuse
* Fractures (eg. ribs, long bone spiral, multiple in different stages of healing), bruises (eg. trunk, ear, neck; in pattern of implement), burns (eg. cigarette, buttocks/thighs), subdural hematomas/retinal hemorrhages (“shaken baby syndrome”). * During exam, children often avoid eye contact. * Red flags include history inconsistent with degree or type of injury (eg. 2-month-old rolling out of bed or falling down stairs), delayed medical care, caregiver story changes with retelling. * Abuser is usually the biological mother. * 40% of deaths related to child abuse or neglect occur in children \< 1 year old.
33
Child Abuse: Sexual Abuse
* genital, anal, or oral trauma * STIs * UTIs * Abuser is known to victim and is usually male. * Peak incidence is 9–12 years old.
34
Psychopathology: * failure to provide a child with adequate food, shelter, supervision, education, and/or affection * mmost common form of child maltreatment * presents with poor hygiene, malnutrition, withdrawal, impaired social/emotional development, and failure to thrive * must be reported to local child protective services
Child Neglect
35
Psychopathology: * parents perceive the child as especially susceptible to illness or injury * usually follows a serious illness or life-threatening event * can result in missed school or overuse of medical services
Vulnerable Child Syndrome
36
Childhood and Early-Onset Disorders: * onset before age 12 * at least 6 months of limited attention span and/or poor impulse control * characterized by hyperactivity, impulsivity, and/or inattention in multiple settings (school, home, places of worship, etc) * normal intelligence, but commonly coexists with difficulties in school * often persists into adulthood * Treatment: * stimulants (eg. methylphenidate) +/– cognitive behavioral therapy (CBT) * alternatives include Atomoxetine, Guanfacine, and Clonidine
Attention-Deficit Hyperactivity Disorder
37
Childhood and Early-Onset Disorders: * characterized by poor social interactions, social communication deficits, repetitive/ritualized behaviors, restricted interests * must present in early childhood * may be accompanied by intellectual disability * rarely accompanied by unusual abilities (savants) * more common in boys * associated with ↑ head/brain size
Autism Spectrum Disorder
38
Childhood and Early-Onset Disorders: * repetitive and pervasive behavior violating the basic rights of others or societal norms (eg. aggression to people and animals, destruction of property, theft) * after age 18 * often reclassified as antisocial personality disorder * treated with psychotherapy such as CBT
Conduct Disorder
39
Childhood and Early-Onset Disorders: * onset before age 10 * severe and recurrent temper outbursts out of proportion to situation * child is constantly angry and irritable between outbursts * Treatment: * Stimulants * Antipsychotics * CBT
Disruptive Mood Dysregulation Disorder
40
Childhood and Early-Onset Disorders: * enduring pattern of hostile, defiant behavior toward authority figures in the absence of serious violations of social norms * Treatment: * psychotherapy such as CBT
Oppositional Defiant Disorder
41
Childhood and Early-Onset Disorders: * overwhelming fear of separation from home or attachment figure lasting ≥ 4 weeks * can be normal behavior up to age 3–4 * may lead to factitious physical complaints to avoid school * Treatment: * CBT * Play Therapy * Family Therapy
Separation Anxiety Disorder
42
Childhood and Early-Onset Disorders: * onset before age 18 * characterized by sudden, rapid, recurrent, nonrhythmic, stereotyped motor and vocal tics that persist for \> 1 year * coprolalia (involuntary obscene speech) found in only 40% of patients * associated with OCD and ADHD * Treatment: * Psychoeducation * Behavioral Therapy * for intractable and distressing tics, high-potency antipsychotics (eg. Haloperidol, Fluphenazine), Tetrabenazine, α2-Agonists (eg. Guanfacine, Clonidine), or atypical antipsychotics may be used
Tourette Syndrome
43
Orientation
* patient’s ability to know who he or she is, where he or she is, and the date and time * Common Causes of Loss of Orientation: * alcohol * drugs * fluid/electrolyte imbalance * head trauma * hypoglycemia * infection * nutritiona deficiencies * hypoxi * Order of Loss: time → place → person
44
Amnesias: inability to remember things that occurred before a CNS insult
Retrograde Amnesia
45
Amnesias: inability to remember things that occurred after a CNS insult (↓ acquisition of new memory)
Anterograde Amnesia
46
Amnesias: * amnesia (anterograde \> retrograde) caused by vitamin B1 deficiency and associated destruction of mammillary bodies * seen in alcoholics as a late neuropsychiatric manifestation of Wernicke encephalopathy * confabulations are characteristic
Korsakoff Syndrome
47
Dissociative Disorders: * persistent feelings of detachment or estrangement from one’s own body, thoughts, perceptions, and actions (depersonalization) or one’s environment (derealization) * intact reality testing (vs. psychosis)
Depersonalization/Derealization Disorder
48
Dissociative Disorders: inability to recall important personal information, usually subsequent to severe trauma or stress
Dissociative Amnesia
49
Dissociative Disorders: * formerly known as Multiple Personality Disorder * presence of 2 or more distinct identities or personality states * more common in women * associated with history of sexual abuse, PTSD, depression, substance abuse, borderline personality, somatoform conditions * may be accompanied by dissociative fugue (abrupt travel or wandering associated with traumatic circumstances)
Dissociative Identity Disorder
50
Psychopathology: * “waxing and waning” level of consciousness with acute onset * rapid ↓ in attention span and level of arousal * characterized by disorganized thinking, hallucinations (often visual), illusions, misperceptions, disturbance in sleepwake cycle, cognitive dysfunction, agitation. * usually 2° to other illness (eg. CNS disease, infection, trauma, substance abuse/withdrawal, metabolic/electrolyte disturbances, hemorrhage, urinary/fecal retention) * most common presentation of altered mental status in inpatient setting, especially in the intensive care unit and with prolonged hospital stays * EEG may show diffuse slowing * treatment is aimed at identifying and addressing underlying condition * use antipsychotics acutely as needed * avoid Benzodiazepines * may be caused by medications (eg. anticholinergics), especially in the elderly * reversible.
Delirium
51
Psychopathology: * distorted perception of reality characterized by delusions, hallucinations, and/or disorganized thought/speech * can occur in patients with medical illness, psychiatric illness, or both
Psychosis
52
Psychosis: * unique, false, fixed, idiosyncratic beliefs that persist despite the facts and are not typical of a patient’s culture or religion (eg. thinking aliens are communicating with you) * types include erotomanic, grandiose, jealous, persecutory, somatic, mixed, and unspecified
Delusions
53
Psychosis: speech may be incoherent (“word salad”), tangential, or derailed (“loose associations”)
Disorganized Thought
54
Psychosis: * perceptions in the absence of external stimuli (eg. seeing a light that is not actually present) * contrast with illusions, misperceptions of real external stimuli
Hallucinations
55
Types of Hallucinations
* Visual—more commonly a feature of medical illness (eg. drug intoxication) than psychiatric illness * Auditory—more commonly a feature of psychiatric illness (eg. schizophrenia) than medical illness * Olfactory—often occur as an aura of temporal lobe epilepsy (eg. burning rubber) and in brain tumors * Gustatory—rare, but seen in epilepsy * Tactile—common in alcohol withdrawal and stimulant use (eg. cocaine, amphetamines), delusional parasitosis, “cocaine crawlies” * Hypnagogic—occurs while going to sleep, sometimes seen in narcolepsy * Hypnopompic—occurs while waking from sleep (“pompous upon awakening”), sometimes seen in narcolepsy
56
Psychopathology: * chronic mental disorder with periods of psychosis, disturbed behavior and thought, and decline in functioning lasting ≥ 6 months (including prodrome and residual symptoms) * associated with ↑ dopaminergic activity, ↓ dendritic branching * frequent cannabis use is associated with psychosis in teens * Lifetime Prevalence * 1.5% males \> females * African Americans = Caucasians * presents earlier in men (late teens to early 20s vs. late 20s to early 30s in women) * patients at ↑ risk for suicide * ventriculomegaly on brain imaging * Diagnosis requires ≥ 2 of the following symptoms for ≥ 1 month, and at least 1 of these should include #1–3 (first 4 are “positive symptoms”): 1. Delusions 2. Hallucinations—often auditory 3. Disorganized Speech 4. Disorganized or Catatonic Behavior 5. Negative Symptoms (affective flattening, avolition, anhedonia, asociality, alogia) * Treatment: * Atypical Antipsychotics (eg. Risperidone) are first line * negative symptoms often persist after treatment, despite resolution of positive symptoms *
Schizophrenia
57
Schizophrenia: * ≥ 1 positive symptom(s) lasting \< 1 month * usually stress related
Brief Psychotic Disorder
58
Schizophrenia: * ≥ 2 symptoms * lasting 1–6 months
Schizophreniform Disorder
59
Schizophrenia: * meets criteria for Schizophrenia in addition to major mood disorder (major depressive or bipolar) * to differentiate from a major mood disorder with psychotic features, patient must have \> 2 weeks of psychotic symptoms without major mood episode
Schizoaffective Disorder
60
Psychopathology: * fixed, persistent, false belief system lasting \> 1 month * functioning otherwise not impaired (eg. a woman who genuinely believes she is married to a celebrity when, in fact, she is not) * can be shared by individuals in close relationships (folie à deux)
Delusional Disorder
61
Psychopathology: * characterized by an abnormal range of moods or internal emotional states and loss of control over them * severity of moods causes distress and impairment in social and occupational functioning * includes major depressive, bipolar, dysthymic, and cyclothymic disorders * episodic superimposed psychotic features (delusions, hallucinations, disorganized speech/behavior) may be present
Mood Disorder
62
Psychopathology: * distinct period of abnormally and persistently elevated, expansive, or irritable mood and abnormally and persistently ↑ activity or energy lasting ≥ 1 week * often disturbing to patient and causes marked functional impairment and oftentimes hospitalization * Diagnosis requires hospitalization or at least 3 of the following: * Distractibility * Impulsivity/Indiscretion—seeks pleasure without regard to consequences (hedonistic) * Grandiosity—inflated self-esteem * Flight of Ideas—racing thoughts * ↑ Goal-Directed Activity/Psychomotor Agitation * ↓ Need for Sleep * Talkativeness or Pressured Speech
Manic Episode Manics **DIG FAST**: * **D**istractibility * **I**mpulsivity/**I**ndiscretion * **G**randiosity * **F**light of Ideas * ↑ Goal-Directed **A**ctivity/Psychomotor **A**gitation * ↓ Need for **S**leep * **T**alkativeness or Pressured Speech
63
Psychopathology: * similar to a manic episode except mood disturbance is not severe enough to cause marked impairment in social and/or occupational functioning or to necessitate hospitalization * no psychotic features * lasts ≥ 4 consecutive days
Hypomanic Episode
64
Bipolar Disorder (Manic Depression)
* _Bipolar I_—defined by presence of at least 1 manic episode +/− a hypomanic or depressive episode (may be separated by any length of time) * _Bipolar II_—defined by presence of a hypomanic and a depressive episode (no history of manic episodes) * Patient’s mood and functioning usually normalize between episodes. * Use of antidepressants can destabilize mood. * High suicide risk. * Treatment: * Mood Stabilizers (eg. Lithium, Valproic Acid, Carbamazepine, Lamotrigine) * Atypical Antipsychotics
65
Psychopathology: * milder form of bipolar disorder lasting ≥ 2 years * fluctuating between mild depressive and hypomanic symptoms
Cyclothymic Disorder
66
Psychopathology: * episodes characterized by at least 5 of the 9 diagnostic symptoms lasting ≥ 2 weeks (symptoms must include patient-reported depressed mood or anhedonia) * screen for history of manic episodes to rule out bipolar disorder * Diagnostic Symptoms: * Depressed Mood * Sleep Disturbance * Loss of Interest (Anhedonia) * Guilt or Feelings of Worthlessness * Energy Loss and Fatigue * Concentration Problems * Appetite/Weight Changes * Psychomotor Retardation or Agitation * Suicidal Ideations * Patients with depression typically have the following changes in their sleep stages: * ↓ slow-wave sleep * ↓ REM latency * ↑ REM early in sleep cycle * ↑ total REM sleep * repeated nighttime awakenings * early-morning awakening (terminal insomnia) * Treatment: * CBT and SSRIs are first line. * SNRIs, Mirtazapine, and Bupropion can also be considered. * Electroconvulsive Therapy (ECT) in treatment-resistant patients.
Major Depressive Disorder SIG E CAPS: * **S**leep Disturbance * Loss of **I**nterest (Anhedonia) * **G**uilt or Feelings of Worthlessness * **E**nergy Loss and Fatigue * **C**oncentration Problems * **A**ppetite/Weight Changes * **P**sychomotor Retardation or Agitation * **S**uicidal Ideations
67
Major Depressive Disorder: * often milder * ≥ 2 depressive symptoms lasting ≥ 2 years with no more than 2 months without depressive symptoms
Persistent Depressive Disorder (Dysthymia)
68
Major Depressive Disorder: * formerly known as Seasonal Affective Disorder * lasting ≥ 2 years with ≥ 2 major depressive episodes associated with seasonal pattern (usually winter) and absence of nonseasonal depressive episodes * atypical symptoms common (eg. hypersomnia, hyperphagia, leaden paralysis)
MDD with Seasonal Pattern
69
Psychopathology: * characterized by mood reactivity (able to experience improved mood in response to positive events, albeit briefly) * “reversed” vegetative symptoms (hypersomnia, hyperphagia), leaden paralysis (heavy feeling in arms and legs), long-standing interpersonal rejection sensitivity * most common subtype of depression * Treatment: * CBT and SSRIs are first line. * MAO inhibitors are effective but not first line because of their risk profile.
Depression with Atypical Features
70
Psychopathology: onset during pregnancy or within 4 weeks of delivery
Postpartum Mood Disturbances
71
Postpartum Mood Disturbances: * 50–85% incidence rate * characterized by depressed affect, tearfulness, and fatigue starting 2–3 days after delivery * usually resolves within 10 days * Treatment: supportive * follow up to assess for possible postpartum depression
Maternal (Postpartum) Blues
72
Postpartum Mood Disturbances: * 10–15% incidence rate * characterized by depressed affect, anxiety, and poor concentration for ≥ 2 weeks * Treatment: CBT and SSRIs are first line
Postpartum Depression
73
Postpartum Mood Disturbances: * 0.1–0.2% incidence rate * characterized by mood-congruent delusions, hallucinations, and thoughts of harming the baby or self * risk factors include history of bipolar or psychotic disorder, first pregnancy, family history, recent discontinuation of psychotropic medication * Treatment: * hospitalization and initiation of atypical antipsychotic * if insufficient, ECT may be used
Postpartum Psychosis
74
Grief
* The five stages of grief per the Kübler-Ross model are Denial, Anger, Bargaining, Depression, and Acceptance (may occur in any order). * Other normal grief symptoms include Shock, Guilt, Sadness, Anxiety, Yearning, and Somatic symptoms that usually occur in waves. * Simple hallucinations of the deceased person are common (eg. hearing the deceased speaking). * Any thoughts of dying are limited to joining the deceased (vs. pathological grief). * Duration varies widely; usually within 6–12 months. * Pathologic grief is persistent, causes functional impairment, and can meet criteria for major depressive episode.
75
Psychotherapy: * rapid-acting method to treat resistant or refractory depression, depression with psychotic symptoms, and acute suicidality * induces grand mal seizure while patient anesthetized * adverse effects include disorientation, temporary headache, partial anterograde/retrograde amnesia usually resolving in 6 months * no absolute contraindications * safe in pregnant and elderly individuals
Electroconvulsive Therapy
76
Suicide
* Most common method in US is firearms; access to guns ↑ risk of suicide completion. * Women try more often; men complete more often. * Family history of completed suicide is another well-known risk factor.
77
Risk Factors for Suicide Completion
**SAD PERSONS** are more likely to complete suicide. * **S**ex (male) * **A**ge (young adult or elderly) * **D**epression * **P**revious attempt (highest risk factor) * **E**thanol or drug use * **R**ational thinking loss (psychosis) * **S**ickness (medical illness) * **O**rganized plan * **N**o spouse or other social support * **S**tated future intent
78
Psychopathology: * inappropriate experience of fear/worry and its physical manifestations (anxiety) incongruent with the magnitude of the perceived stressor * symptoms interfere with daily functioning and are not attributable to another mental disorder, medical condition, or substance abuse * includes panic disorder, phobias, generalized anxiety disorder, and selective mutism * Treatment: * CBT * SSRIs * SNRIs
Anxiety Disorder
79
Psychopathology: * recurrent unexpected panic attacks not associated with a known trigger * periods of intense fear and discomfort peak in 10 minutes with at least 4 of the following: palpitations, paresthesias, depersonalization or derealization, abdominal distress or nausea, intense fear of dying, intense fear of losing control or “going crazy,” lIght-headedness, chest pain, chills, choking, sweating, shaking, shortness of breath * strong genetic component * ↑ risk of suicide * Diagnosis requires attack followed by ≥ 1 month of ≥ 1 of the following: * persistent concern of additional attacks * worrying about consequences of attack * behavioral change related to attacks * symptoms are the systemic manifestations of fear * Treatment: * CBT, SSRIs, and venlafaxine are first line. * Benzodiazepines occasionally used in acute setting.
Panic Disorder **PANICS**: * **P**alpitations * **P**aresthesias * de**P**ersonalization or derealization * **A**bdominal distress or **N**ausea * **I**ntense fear of dying * **I**ntense fear of losing control or “going crazy” * l**I**ght-headedness, * **C**hest pain * **C**hills * **C**hoking * **S**weating * **S**haking * **S**hortness of breath
80
Psychopathology: * severe, persistent (≥ 6 months) fear or anxiety due to presence or anticipation of a specific object or situation * person often recognizes fear is excessive * can be treated with systematic desensitization
Phobia
81
Phobia: * exaggerated fear of embarrassment in social situations (eg. public speaking, using public restrooms) * Treatment: * CBT * SSRIs * Venlafaxine * for performance type (eg. anxiety restricted to public speaking), use β-Blockers or Benzodiazepines as needed
Social Anxiety Disorder
82
Phobia: * irrational fear/anxiety while facing or anticipating ≥ 2 specific situations (eg. open/closed spaces, lines, crowds, public transport) * if severe, patients may refuse to leave their homes * associated with panic disorder * Treatment: * CBT * SSRIs
Agoraphobia
83
Psychopathology: * anxiety lasting \> 6 months unrelated to a specific person, situation, or event * associated with restlessness, irritability, sleep disturbance, fatigue, muscle tension, and difficulty concentrating * Treatment: * CBT, SSRIs, and SNRIs are first line. * Buspirone, TCAs, and Benzodiazepines are second line.
Generalized Anxiety Disorder
84
Psychopathology: * emotional symptoms (anxiety, depression) that occur within 3 months of an identifiable psychosocial stressor (eg. divorce, illness) lasting \< 6 months once the stressor has ended * if symptoms persist \> 6 months after stressor ends, it is GAD * symptoms do not meet criteria for MDD * Treatment: * CBT * SSRIs
Adjustment Disorder
85
Psychopathology: * recurring intrusive thoughts, feelings, or sensations (obsessions) that cause severe distress * relieved in part by the performance of repetitive actions (compulsions) * Ego-Dystonic: behavior inconsistent with one’s own beliefs and attitudes (vs. obsessive-compulsive personality disorder, Ego-Syntonic) * associated with Tourette syndrome * Treatment: * CBT, SSRIs, Venlafaxine, and Clomipramine are first line
Obsessive-Compulsive Disorder
86
Obsessive-Compulsive Disorder: * preoccupation with minor or imagined defect in appearance → significant emotional distress or impaired functioning * patients often repeatedly seek cosmetic treatment * Treatment: CBT
Body Dysmorphic Disorder
87
Psychopathology: * experiencing a potentially life-threatening situation (eg. serious injury, rape, witnessing death) → persistent hyperarousal, avoidance of associated stimuli, intrusive re-experiencing of the event (nightmares, flashbacks), changes in cognition or mood (fear, horror, distress) * disturbance lasts \> 1 month with significant distress or impaired socialoccupational functioning * Treatment: * CBT, SSRIs, and Venlafaxine are first line. * Prazosin can reduce nightmares.
Post-Traumatic Stress Disorder Having PTSD is **HARD**. * persistent **H**yperarousal * **A**voidance of associated stimuli * intrusive **R**e-experiencing of the event (nightmares, flashbacks) * changes in cognition or mood (fear, horror, **D**istress)
88
Psychopathology: * lasts between 3 days and 1 month * Treatment: * CBT * pharmacotherapy is usually not indicated
Acute Stress Disorder
89
Diagnostic Criteria by Symptom Duration
90
Personality: an enduring, repetitive pattern of perceiving, relating to, and thinking about the environment and oneself
Personality Trait
91
Personality: * inflexible, maladaptive, and rigidly pervasive pattern of behavior causing subjective distress and/or impaired functioning * person is usually not aware of problem (ego-syntonic) * usually presents by early adulthood
Personality Disorder Three Clusters: * A—Weird * B—Wild * C—Worried
92
Personality Disorders: * odd or eccentric * inability to develop meaningful social relationships * no psychosis * genetic association with schizophrenia * “weird”
Cluster A Personality Disorders Cluster **A**: **A**ccusatory, **A**loof, **A**wkward
93
Cluster A Personality Disorders: pervasive distrust (**A**ccusatory) and suspiciousness of others and a profoundly cynical view of the world
Paranoid
94
Cluster A Personality Disorders: * voluntary social withdrawal (**A**loof) * limited emotional expression * content with social isolation (vs. avoidant)
Schizoid
95
Cluster A Personality Disorders: * eccentric appearance * odd beliefs or magical thinking * interpersonal **A**wkwardness
Schizotypal
96
Personality Disorders: * dramatic, emotional, or erratic * genetic association with mood disorders and substance abuse * “wild”
Cluster B Personality Disorders Cluster **B**: **B**ad, **B**orderline, flam**B**oyant, must be the **B**est
97
Cluster B Personality Disorders: * disregard for and violation of rights of others with lack of remorse, criminality, and impulsivity * males \> females * must be ≥ 18 years old and have history of conduct disorder before age 15 * conduct disorder if \< 18 years old * "**B**ad"
Antisocial
98
Cluster B Personality Disorders: * unstable mood and interpersonal relationships, impulsivity, self-mutilation, suicidality, and sense of emptiness * females \> males * splitting is a major defense mechanism * Treatment: dialectical behavior therapy
**B**orderline
99
Cluster B Personality Disorders: * excessive emotionality and excitability, attention seeking, sexually provocative, and overly concerned with appearance * flam**B**oyant
Histrionic
100
Cluster B Personality Disorders: * grandiosity and sense of entitlement * lacks empathy and requires excessive admiration * often demands the “**B**est” and reacts to criticism with rage
Narcissistic
101
Personality Disorders: * anxious or fearful * genetic association with anxiety disorders * “worried”
Cluster C Personality Disorders Cluster **C**: **C**owardly, obsessive-**C**ompulsive, **C**lingy
102
Cluster C Personality Disorders: * hypersensitive to rejection, socially inhibited, timid, feelings of inadequacy, desires relationships with others (vs. schizoid) * **C**owardly
Avoidant
103
Cluster C Personality Disorders: * preoccupation with order, perfectionism, and control * Ego-Syntonic: behavior consistent with one’s own beliefs and attitudes (vs. OCD)
Obsessive-**C**ompulsive
104
Cluster C Personality Disorders: * excessive need for support * low self-confidence * patients often get stuck in abusive relationships * submissive and **C**lingy
Dependent
105
Psychopathology: * symptoms are intentional, motivation is intentional * patient consciously fakes, profoundly exaggerates, or claims to have a disorder in order to attain a specific 2° (external) gain (eg. avoiding work, obtaining compensation) * poor compliance with treatment or follow-up of diagnostic tests * complaints cease after gain (vs. factitious disorder)
Malingering
106
Psychopathology: * symptoms are intentional, motivation is unconscious * patient consciously creates physical and/or psychological symptoms in order to assume “sick role” and to get medical attention and sympathy (1° [internal] gain)
Factitious Disorders
107
Factitious Disorders: * also known as Munchausen syndrome * chronic factitious disorder with predominantly physical signs and symptoms * characterized by a history of multiple hospital admissions and willingness to undergo invasive procedures * more common in women and healthcare workers
Factitious Disorder Imposed on Self
108
Factitious Disorders: * also known as Munchausen syndrome by proxy * illness in a child or elderly patient is caused or fabricated by the caregiver * motivation is to assume a sick role by proxy * form of child/elder abuse
Factitious Disorder Imposed on Another
109
Psychopathology: * symptoms are unconscious, motivation is unconscious * category of disorders characterized by physical symptoms causing significant distress and impairment * symptoms not intentionally produced or feigned * more common in women
Somatic Symptom and Related Disorders
110
Somatic Symptom and Related Disorders: * variety of bodily complaints (eg. pain, fatigue) lasting for months to years * associated with excessive, persistent thoughts and anxiety about symptoms * may co-occur with medical illness * Treatment: * regular office visits with the same physician in combination with psychotherapy
Somatic Symptom Disorder
111
Somatic Symptom and Related Disorders: * also known as functional neurologic symptom disorder * loss of sensory or motor function (eg. paralysis, blindness, mutism), often following an acute stressor * patient may be aware of but indifferent toward symptoms (“la belle indifférence”) * more common in females, adolescents, and young adults
Conversion Disorder
112
Somatic Symptom and Related Disorders: * also known as hypochondriasis * excessive preoccupation with acquiring or having a serious illness, often despite medical evaluation and reassurance * minimal somatic symptoms
Illness Anxiety Disorder
113
Psychopathology: most common in young females
Eating Disorders
114
Eating Disorders: * intense fear of weight gain and distortion or overvaluation of body image leading to restriction of caloric intake and severe weight loss (BMI \< 18.5 kg/m2) * restricting and binge/purge subtypes * associated with ↓ bone density (often irreversible), amenorrhea (due to loss of pulsatile GnRH secretion), lanugo, anemia, and electrolyte disturbances * commonly coexists with depression * psychotherapy and nutritional rehabilitation are first line * pharmacotherapy includes SSRIs for comorbid anxiety and/or depression
Anorexia Nervosa
115
Eating Disorders: * ↑ insulin → hypophosphatemia, hypokalemia, hypomagnesemia → cardiac complications, rhabdomyolysis, seizures * can occur in significantly malnourished patients
Refeeding Syndrome
116
Eating Disorders: * binge eating with recurrent inappropriate compensatory behaviors (eg. self-induced vomiting, using laxatives or diuretics, fasting, excessive exercise) occurring weekly for at least 3 months and overvaluation of body image * body weight often maintained within normal range * associated with parotitis, enamel erosion, electrolyte disturbances (eg. hypokalemia, hypochloremia), metabolic alkalosis, dorsal hand calluses from induced vomiting (Russell sign) * Treatment: * psychotherapy * nutritional rehabilitation * antidepressants (eg. SSRIs) * Bupropion is contraindicated due to seizure risk
Bulimia Nervosa
117
Eating Disorders: * regular episodes of excessive, uncontrollable eating without inappropriate compensatory behaviors * ↑ risk of diabetes * Treatment: * psychotherapy such as CBT is first line * SSRIs * Lisdexamfetamine
Binge Eating Disorder
118
Psychopathology: persistent cross-gender identification that leads to persistent distress with sex assigned at birth
Gender Dysphoria
119
Gender Dysphoria: desire to live as the opposite sex, often through surgery or hormone treatment
Transsexualism
120
Gender Dysphoria: * paraphilia, not gender dysphoria * wearing clothes (eg. vest) of the opposite sex (cross-dressing)
Transvestism
121
Psychopathology: * Includes sexual desire disorders (hypoactive sexual desire or sexual aversion), sexual arousal disorders (erectile dysfunction), orgasmic disorders (anorgasmia, premature ejaculation), and sexual pain disorders (dyspareunia, vaginismus) * Differentials: * Drug Side Effects (eg. antihypertensives, antipsychotics, SSRIs, ethanol) * Medical Disorders (eg. depression, diabetes, STIs) * Psychological or Performance Anxiety (eg. nighttime erections [nocturnal tumescence])
Sexual Dysfunction
122
Psychopathology: * inconsolable periods of terror with screaming in the middle of the night * occurs during slow-wave/deep (stage N3) sleep * most common in children * occurs during non-REM sleep (no memory of the arousal episode) as opposed to nightmares that occur during REM sleep (remembering a scary dream) * cause unknown, but triggers include emotional stress, fever, or lack of sleep * usually self limited
Sleep Terror Disorder
123
Psychopathology: * urinary incontinence ≥ 2 times/week for ≥ 3 months in person \> 5 years old * First-Line Treatment: * behavioral modification (eg. scheduled voids) * positive reinforcement * For Refractory Cases: * bedwetting alarm * oral Desmopressin (ADH analog; preferred over imipramine due to more favorable side effect profile)
Enuresis
124
Psychopathology: * disordered regulation of sleep-wake cycles characterized by excessive daytime sleepiness (despite feeling rested upon waking) and “sleep attacks” (rapid-onset, overwhelming sleepiness) * caused by ↓ hypocretin (orexin) production in lateral hypothalamus * strong genetic component * Also associated with: * hypnagogic (just before going to sleep) or hypnopompic (just before awakening; “pompous upon awakening”) hallucinations * nocturnal and narcoleptic sleep episodes that start with REM sleep (sleep paralysis) * cataplexy (loss of all muscle tone following strong emotional stimulus, such as laughter) in some patients * Treatment: * good sleep hygiene (scheduled naps, regular sleep schedule) * daytime stimulants (eg. amphetamines, modafinil) and nighttime sodium oxybate (GHB)
Narcolepsy
125
Substance Use Disorder
Maladaptive pattern of substance use defined as 2 or more of the following signs in 1 year related specifically to substance use: * Tolerance—need more to achieve same effect * Withdrawal—manifesting as characteristic signs and symptoms * substance taken in larger amounts, or over longer time, than desired * persistent desire or unsuccessful attempts to cut down * significant energy spent obtaining, using, or recovering from substance * important social, occupational, or recreational activities reduced * continued use despite knowing substance causes physical and/or psychological problems * Craving * recurrent use in physically dangerous situations * failure to fulfill major obligations at work, school, or home * social or interpersonal conflicts
126
Stages of Change in Overcoming Substance Addiction
1. Precontemplation—not yet acknowledging that there is a problem 2. Contemplation—acknowledging that there is a problem, but not yet ready or willing to make a change 3. Preparation/Determination—getting ready to change behaviors 4. Action/Willpower—changing behaviors 5. Maintenance—maintaining the behavioral changes 6. Relapse—returning to old behaviors and abandoning new changes, does not always happen
127
Psychiatric Emergencies: * Cause: * any drug that ↑ 5-HT. * Psychiatric Drugs: * MAO inhibitors, SSRIs, SNRIs, TCAs, Vilazodone, Vortioxetine * Nonpsychiatric Drugs: * Tramadol, Ondansetron, Triptans, Linezolid, MDMA, Dextromethorphan, Meperidine, St. John’s Wort * **3 A**’s: * ↑ **A**ctivity (neuromuscular) * **A**utonomic stimulation * **A**gitation * symptoms of neuromuscular hyperactivity include clonus, hyperreflexia, hypertonia, tremor, and seizure * symptoms of autonomic stimulation include hyperthermia, diaphoresis, diarrhea * Treatment: * Cyproheptadine (5-HT2 receptor antagonist)
Serotonin Syndrome
128
Psychiatric Emergencies: * Cause: carcinoid tumor of GI tract or lung * diarrhea, flushing, wheezing, and right heart disease (if tumor is in the gut) * Treatement: Octreotide
Carcinoid Syndrome
129
Psychiatric Emergencies: * Cause: * eating tyramine-rich foods (eg. aged cheeses, cured meats, wine) while taking MAO inhibitor * tyramine displaces other neurotransmitters (eg. NE) in the synaptic cleft → ↑ sympathetic stimulation * Treatment: Phentolamine
Hypertensive Crisis
130
Psychiatric Emergencies: * Causes: * antipsychotics + genetic predisposition * myoglobinuria, fever, encephalopathy, vitals unstable, ↑ enzymes (eg. ↑ CK), rigidity of muscles (“lead pipe”) * Treatment: * Dantrolene * Dopamine Agonist (eg. Bromocriptine) * discontinue causative agent
Neuroleptic Malignant Syndrome **M**alignant **FEVER**: * **M**yoglobinuria * **F**ever * **E**ncephalopathy * **V**itals unstable * ↑ **E**nzymes (eg. ↑ CK) * **R**igidity of muscles (“lead pipe”)
131
Psychiatric Emergencies: * Cuase: * inhaled anesthetics, Succinylcholine + genetic predisposition * fever and severe muscle contractions * Treatment: Dantrolene
Malignant Hyperthermia
132
Psychiatric Emergencies: * Cause: * alcohol withdrawal * occurs 2–4 days after last drink * classically seen in hospital setting when inpatient cannot drink * altered mental status (eg. hallucinations), autonomic hyperactivity, anxiety, seizures, tremors, psychomotor agitation, insomnia, nausea * Treatement: * Benzodiazepines (eg. Chlordiazepoxide, Lorazepam, Diazepam)
Delirium Tremens
133
Psychiatric Emergencies: * Cause: * typical antipsychotics * anticonvulsants (eg. Carbamazepine) * Metoclopramide * sudden onset of muscle spasm, stiffness, oculogyric crisis that occurs within hours to days after medication use * can lead to laryngospasm requiring intubation * Treatment: * Benztropine * Diphenhydramine
Acute Dystonia
134
Psychiatric Emergencies: * Cause: * change in lithium dosage or health status (narrow therapeutic window) * concurrent use of Thiazides, ACE Inhibitors, NSAIDs, or other nephrotoxic agents * nausea, vomiting, slurred speech, hyperreflexia, seizures, ataxia, and nephrogenic diabetes insipidus * Treatment: * discontinue lithium * hydrate aggressively with isotonic sodium chloride * consider hemodialysis
Lithium Toxicity
135
Psychiatric Emergencies: * Cause: TCA overdose * respiratory depression, hyperpyrexia, prolonged QT interval * **Tri**-**C**’s: * **C**onvulsions * **C**oma * **C**ardiotoxicity (arrhythmia due to Na+ channel inhibition) * Treatment: * supportive treatment * monitor ECG * NaHCO3 (prevents arrhythmia) * activated charcoal
Tricyclic Antidepressant Toxicity
136
Psychoactive Drug Intoxication and Withdrawal: * Intoxication: * nonspecific, mood elevation, ↓ anxiety, sedation, behavioral disinhibition, respiratory depression * Withdrawal: * nonspecific, anxiety, tremor, seizures, insomnia
Depressants
137
Psychoactive Drug Intoxication and Withdrawal: * Intoxication: * emotional lability, slurred speech, ataxia, coma, blackouts * serum γ-glutamyltransferase (GGT)—sensitive indicator of alcohol use * AST value is 2× ALT value * Withdrawal: * 3–36 hr: tremors, insomnia, GI upset, diaphoresis, mild agitation * 6–48 hr: withdrawal seizures * 12–48 hr: alcoholic hallucinosis (usually visual) * 48–96 hr: delirium tremens (DTs) * Treatment: Benzodiazepines
Alcohol To**AST 2 AL**cohol: **AST** value is **2**× **AL**T value
138
Psychoactive Drug Intoxication and Withdrawal: * Intoxication: * euphoria, respiratory and CNS depression, ↓ gag reflex, pupillary constriction (pinpoint pupils), seizures (overdose) * most common * cause of drug overdose death * Treatment: Naloxone * Withdrawal: * sweating, dilated pupils, piloerection (“cold turkey”), fever, rhinorrhea, lacrimation, yawning, nausea, stomach cramps, diarrhea (“flu-like” symptoms) * Treatment: * long-term support * Methadone * Buprenorphine
Opioids
139
Psychoactive Drug Intoxication and Withdrawal: * Intoxication: * low safety margin * marked respiratory depression * Treatment: * symptom management (eg. assist respiration, ↑ BP) * Withdrawal: * delirium * life-threatening cardiovascular collapse
Barbiturates
140
Psychoactive Drug Intoxication and Withdrawal: * Intoxication: * greater safety margin * ataxia * minor respiratory depression * Treatment: * Flumazenil (Benzodiazepine receptor antagonist, but rarely used as it can precipitate seizures) * Withdrawal: * sleep disturbance, depression, rebound anxiety, and seizure
Benzodiazepines
141
Psychoactive Drug Intoxication and Withdrawal: * Intoxication: * nonspecific, mood elevation, psychomotor agitation, insomnia, cardiac arrhythmias, tachycardia, and anxiety * Withdrawal: * nonspecific, post-use “crash,” including depression, lethargy, ↑ appetite, sleep disturbance, and vivid nightmares
Stimulants
142
Psychoactive Drug Intoxication: * euphoria, grandiosity, pupillary dilation, prolonged wakefulness and attention, hypertension, tachycardia, anorexia, paranoia, fever * skin excoriations with methamphetamine use * Severe: cardiac arrest, seizures * Treatment: * Benzodiazepines for agitation and seizures
Amphetamines
143
Psychoactive Drug Intoxication: * impaired judgment, pupillary dilation, hallucinations (including tactile), paranoid ideations, angina, and sudden cardiac death * chronic use may lead to perforated nasal septum due to vasoconstriction and resulting ischemic necrosis * Treatment: * α-Blockers * Benzodiazepines * β-Blockers not recommended
Cocaine
144
Psychoactive Drug Intoxication and Withdrawal: * Intoxication: * restlessness, ↑ diuresis, and muscle twitching * Withdrawal: * headache, difficulty concentrating, and flu-like symptoms
Caffeine
145
Psychoactive Drug Intoxication and Withdrawal: * Intoxication: * restlessness * Withdrawal: * irritability, anxiety, restlessness, and difficulty concentrating * Treatment: * nicotine patch, gum, or lozenges * Bupropion/Varenicline
Nicotine
146
Psychoactive Drug Intoxication: * hallucinogen * violence, impulsivity, psychomotor agitation, nystagmus, tachycardia, hypertension, analgesia, psychosis, delirium, and seizures * trauma is the most common complication
Phencyclidine (PCP)
147
Psychoactive Drug Intoxication: * hallucinogen * perceptual distortion (visual, auditory), depersonalization, anxiety, paranoia, psychosis, possible flashbacks
Lysergic Acid Diethylamide
148
Psychoactive Drug Intoxication and Withdrawal: * Intoxication: * euphoria, anxiety, paranoid delusions, perception of slowed time, impaired judgment, social withdrawal, ↑ appetite, dry mouth, conjunctival injection, and hallucinations * pharmaceutical form is Dronabinol: used as antiemetic (chemotherapy) and appetite stimulant (in AIDS) * Withdrawal: * irritability, anxiety, depression, insomnia, restlessness, and ↓ appetite
Marijuana (Cannabinoid)
149
Psychoactive Drug Intoxication and Withdrawal: * Intoxication: * hallucinogenic stimulant * euphoria, disinhibition, hyperactivity, distorted sensory and time perception, and teeth clenching * life-threatening effects include hypertension, tachycardia, hyperthermia, hyponatremia, and serotonin syndrome * Withdrawal: * depression, fatigue, change in appetite, difficulty concentrating, and anxiety
MDMA (Ecstasy)
150
Psychopathology: * physiologic tolerance and dependence on alcohol with symptoms of withdrawal when intake is interrupted * Complications: * alcoholic cirrhosis, hepatitis, pancreatitis, peripheral neuropathy, and testicular atrophy * Treatment: * Disulfiram (to condition the patient to abstain from alcohol use) * Acamprosate * Naltrexone (reduces cravings), * supportive care * Support groups such as Alcoholics Anonymous are helpful in sustaining abstinence and supporting patient and family.
Alcoholism
151
Psychopathology: * caused by vitamin B1 deficiency * triad of confusion, ophthalmoplegia, and ataxia (Wernicke encephalopathy) * may progress to irreversible memory loss, confabulation, and personality change (Korsakoff syndrome) * symptoms may be precipitated by giving dextrose before administering vitamin B1 to a patient with thiamine deficiency * associated with periventricular hemorrhage/necrosis of mammillary bodies * Treatment: IV Vitamin B1
Wernicke-Korsakoff Syndrome
152
Psychopharmacology: ADHD
Stimulants * Methylphenidate * Amphetamines
153
Psychopharmacology: Alcohol Withdrawal
Benzodiazepines * Chlordiazepoxide * Lorazepam * Diazepam
154
Psychopharmacology: Bipolar Disorder
* Lithium * Valproic Acid * Carbamazepine * Lamotrigine * Atypical Antipsychotics
155
Psychopharmacology: Bulimia Nervosa
SSRIs
156
Psychopharmacology: Depression
SSRIs
157
Psychopharmacology: Generalized Anxiety Disorder
* SSRIs * SNRIs
158
Psychopharmacology: Obsessive-Compulsive Disorder
* SSRIs * Venlafaxine * Clomipramine
159
Psychopharmacology: Panic Disorder
* SSRIs * Venlafaxine * Benzodiazepines
160
Psychopharmacology: PTSD
* SSRIs * Venlafaxine
161
Psychopharmacology: Schizophrenia
Atypical Antipsychotics
162
Psychopharmacology: Social Anxiety Disorder
* SSRIs * Venlafaxine * Performance Only: * β-Blockers * Benzodiazepines
163
Psychopharmacology: Tourette Syndrome
* Antipsychotics * Fluphenazine * Risperidone * Tetrabenazine
164
Central Nervous System Stimulants
* Methylphenidate * Dextroamphetamine * Methamphetamine
165
Psychopharmacology: * ↑ catecholamines in the synaptic cleft, especially norepinephrine and dopamine * used for ADHD and narcolepsy * causes nervousness, agitation, anxiety, insomnia, anorexia, tachycardia, hypertension, weight loss, and tics
Central Nervous System Stimulants
166
Typical Antipsychotics
* Haloperidol * Pimozide * Trifluoper**azine** * Fluphen**azine** * Thiorid**azine** * Chlorprom**azine**
167
Psychopharmacology: * block dopamine D2 receptor (↑ cAMP) * used for Schizophrenia (1° positive symptoms), psychosis, bipolar disorder, delirium, Tourette syndrome, Huntington disease, and OCD
Typical Antipsychotics
168
Typical Antipsychotics: High Potency
**Try** to **Fl**y **High**: * **Tri**fluoperazine * **Fl**uphenazine * **H**aloperidol \*more neurologic side effects (eg. extrapyramidal symptoms [EPS])
169
Typical Antipsychotics: Low Potency
**Ch**eating **Th**ieves are **low**: * **Ch**lorpromazine * **Th**ioridazine \*more anticholinergic, antihistamine, α1-blockade effects
170
Typical Antipsychotics: Adverse Effects
* lipid soluble → stored in body fat → slow to be removed from body * Endocrine: dopamine receptor antagonism → hyperprolactinemia → galactorrhea, oligomenorrhea, gynecomastia * Metabolic: dyslipidemia, weight gain, hyperglycemia * Antimuscarinic: dry mouth, constipation * Antihistamine: sedation * α1-Blockade: orthostatic hypotension * Cardiac: QT prolongation * Ophthalmologic: * **C**hlorpromazine—**C**orneal deposits * **T**hioridazine—re**T**inal deposits * Neuroleptic Malignant Syndrome
171
Extrapyramidal Symptoms
**ADAPT**: * Hours to Days: * **A**cute **D**ystonia (muscle spasm, stiffness, oculogyric crisis) * Treatment: * Benztropine * Diphenhydramine * Days to Months: * **A**kathisia (restlessness) * Treatment: * β-Blockers * Benztropine * Benzodiazepines * **P**arkinsonism (bradykinesia) * Treatment: * Benztropine * Amantadine * Months to Years: * **T**ardive Dyskinesia (orofacial chorea) * Treatment: * switch to atypical antipsychotic (eg. Clozapine) * Tetrabenazine * Reserpine
172
Atypical Antipsychotics
* Aripiprazole * Asen**apine** * Cloz**apine** * Olanz**apine** * Queti**apine** * Ilo**peridone** * Pali**peridone** * Ris**peridone** * Luras**idone** * Zipras**idone**
173
Psychopharmacology: * not completely understood * most are D2 antagonists (Aripiprazole is D2 partial agonist) * varied effects on 5-HT2, dopamine, and α- and H1-receptors * used for schizophrenia—both positive and negative symptoms * also used for bipolar disorder, OCD, anxiety disorder, depression, mania, and Tourette syndrome * Clozapine is used for treatment-resistant schizophrenia or schizoaffective disorder and for suicidality in schizophrenia
Atypical Antipsychotics
174
Atypical Antipsychotics: Adverse Effects
* All * prolonged QT interval * fewer EPS and anticholinergic side effects than typical antipsychotics * “-pines” * metabolic syndrome (weight gain, diabetes, hyperlipidemia) * Clozapine * agranulocytosis (monitor WBCs frequently) and seizures (dose related) * Risperidone * hyperprolactinemia (amenorrhea, galactorrhea, gynecomastia) * **O**lanzapine, Cl**O**zapine → **O**besity
175
Psychopharmacology: * MOA not established; possibly related to inhibition of phosphoinositol cascade * used as mood stabilizer for bipolar disorder * treats acute manic episodes and prevents relapse * causes tremor, hypothyroidism, polyuria (causes nephrogenic diabetes insipidus), and teratogenesis * causes Ebstein anomaly in newborn if taken by pregnant mother * narrow therapeutic window requires close monitoring of serum levels * almost exclusively excreted by kidneys * most is reabsorbed at PCT with Na+ * Thiazides (and other nephrotoxic agents) are implicated in toxicity
Lithium **L**i**THIUM**: * **L**ow **T**hyroid (hypothyroidism) * **H**eart (Ebstein anomaly) * **I**nsipidus (nephrogenic diabetes insipidus) * **U**nwanted **M**ovements (tremor)
176
Psychopharmacology: * stimulates 5-HT1A receptors * used for generalized anxiety disorder * does not cause sedation, addiction, or tolerance * takes 1–2 weeks to take effect * does not interact with alcohol (vs. Barbiturates and Benzodiazepines)
Buspirone
177
Antidepressants
178
Selective Serotonin Reuptake Inhibitors (SSRIs)
* Fluoxetine * Fluvoxamine * Paroxetine * Sertraline * Escitalopram * Citalopram
179
Psychopharmacology: * inhibit 5-HT reuptake * normally takes 4–8 weeks to have an effect * used for depression, generalized anxiety disorder, panic disorder, OCD, bulimia, social anxiety disorder, PTSD, premature ejaculation, and premenstrual dysphoric disorder * Adverse Effects * fewer than TCAs * GI distress * SIADH * sexual dysfunction (anorgasmia, ↓ libido)
Selective Serotonin Reuptake Inhibitors (SSRIs)
180
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
* Venlafaxine * Desvenlafaxine * Duloxetine * Levomilnacipran * Milnacipran
181
Psychopharmacology: * inhibit 5-HT and NE reuptake * used for depression, general anxiety disorder, and diabetic neuropathy * Venlafaxine is also indicated for social anxiety disorder, panic disorder, PTSD, and OCD * Duloxetine is also indicated for fibromyalgia * causes ↑ BP, stimulant effects, sedation, nausea
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
182
Tricyclic Antidepressants
* Amitriptyline * Nortriptyline * Imipramine * Desipramine * Clomipramine * Doxepin * Amoxapine
183
Psychopharmacology: * TCAs inhibit 5-HT and NE reuptake * used for major depression, OCD (Clomipramine), peripheral neuropathy, chronic pain, and migraine prophylaxis * nocturnal enuresis (Imipramine, although adverse effects may limit use) * causes sedation, α1-blocking effects including postural hypotension, and atropine-like (anticholinergic) side effects (tachycardia, urinary retention, dry mouth) * 3° _____ (Amitriptyline) have more anticholinergic effects than 2° _____ (Nortriptyline) * can prolong QT interval * **Tri**-**C**’s: * **C**onvulsions * **C**oma * **C**ardiotoxicity (arrhythmia due to Na+ channel inhibition) * also causes respiratory depression and hyperpyrexia * confusion and hallucinations in the elderly due to anticholinergic side effects (Nortriptyline better tolerated in the elderly) * Treatment: NaHCO3 to prevent arrhythmia
Tricyclic Antidepressants
184
Monoamine Oxidase Inhibitors
**MAO** **T**akes **P**ride **I**n **S**hanghai. * **T**ranylcypromine * **P**henelzine * **I**socarboxazid * **S**elegiline (selective MAO-B inhibitor)
185
Psychopharmacology: * nonselective _____ inhibition ↑ levels of amine neurotransmitters (norepinephrine, 5-HT, dopamine) * used for atypical depression, anxiety, and Parkinson disease (selegiline) * causes CNS stimulation and hypertensive crisis, most notably with ingestion of tyramine * contraindicated with SSRIs, TCAs, St. John’s wort, Meperidine, and Dextromethorphan (to prevent serotonin syndrome) * wait 2 weeks after stopping _____ before starting serotonergic drugs or stopping dietary restrictions
Monoamine Oxidase Inhibitors
186
Atypical Antidepressants: * inhibits NE and Dopamine reuptake * also used for smoking cessation * Toxicity: * stimulant effects (tachycardia, insomnia) * headache * seizures in anorexic/bulimic patients * favorable sexual side effect profile
Bupropion
187
Atypical Antidepressants: * α2-antagonist (↑ release of NE and 5-HT), potent 5-HT2 and 5-HT3 receptor antagonist and H1 antagonist * Toxicity: * sedation (which may be desirable in depressed patients with insomnia) * ↑ appetite * weight gain (which may be desirable in elderly or anorexic patients) * dry mouth
Mirtazapine
188
Atypical Antidepressants: * primarily blocks 5-HT2, α1-adrenergic, and H1 receptors * also weakly inhibits 5-HT reuptake * used primarily for insomnia, as high doses are needed for antidepressant effects * Toxicity: * sedation * nausea * priapism * postural hypotension
Trazodone Tra**ZZZ**o**bone**: * sedative * priapism
189
Atypical Antidepressants: * nicotinic ACh receptor partial agonist * used for smoking cessation * Toxicity: * sleep disturbance * may depress mood
Varenicline Vare**nicline** helps **ni**cotine cravings de**cline**.
190
Atypical Antidepressants: * inhibits 5-HT reuptake * 5-HT1A receptor partial agonist * used for major depressive disorder * Toxicity: * headache * diarrhea * nausea * ↑ weight * anticholinergic effects * may cause serotonin syndrome if taken with other serotonergic agents
Vilazodone
191
Atypical Antidepressants: * inhibits 5-HT reuptake * 5-HT1A receptor agonist and 5-HT3 receptor antagonist * used for major depressive disorder * Toxicity: * nausea * sexual dysfunction * sleep disturbances (abnormal dreams) * anticholinergic effects * may cause serotonin syndrome if taken with other serotonergic agents
Vortioxetine
192
Intravenous drug users at ↑ risk for \_\_\_\_\_.
* hepatitis * HIV * abscesses * bacteremia * right-heart endocarditis
193
Opioid Withdrawal and Detoxification: long-acting oral opiate used for heroin detoxification or long-term maintenance therapy
Methadone
194
Opioid Withdrawal and Detoxification: * sublingual B\_\_\_\_\_ (partial agonist) is absorbed and used for maintenance therapy * N\_\_\_\_\_ (antagonist, not orally bioavailable) is added to lower IV abuse potential
Buprenorphine + Naloxone
195
Opioid Withdrawal and Detoxification: * long-acting opioid given IM or as nasal spray to treat acute overdose in unconscious individual * also used for relapse prevention once detoxified
Naltrexone Use Nal**trex**one for the long **trex** back to sobriety.